|
COURT OF APPEALS DECISION DATED AND RELEASED August 31, 1995 |
NOTICE |
|
A party may file with the
Supreme Court a petition to review an adverse decision by the Court of
Appeals. See § 808.10 and Rule 809.62(1), Stats. |
This opinion is subject to
further editing. If published, the
official version will appear in the bound volume of the Official Reports. |
No. 94-0404
STATE
OF WISCONSIN IN COURT OF
APPEALS
DISTRICT IV
GWENDOLYN LAWVER,
and MARVIN LAWVER,
Husband and Wife,
Plaintiffs-Respondents,
CERTAIN UNDERWRITERS
AT INTEREST,
and VENTURE I,
Plaintiffs-Appellants,
v.
MARSHFIELD CLINIC,
and WISCONSIN
PATIENTS' COMPENSATION FUND,
Defendants-Respondents.
APPEAL from a judgment
of the circuit court for Wood County:
JOHN V. FINN, Judge. Affirmed.
Before Eich, C.J.,
Dykman and Vergeront, JJ.
PER
CURIAM. Venture I and its stop-loss insurer,
Certain Underwriters at Interest, appeal from a judgment allocating all
proceeds of a malpractice settlement to Gwendolyn and Marvin Lawver. The issue on appeal concerns Venture I's
subrogation claim to those proceeds. We
conclude that the trial court properly denied its claim, and we therefore
affirm.
Venture I employed
Gwendolyn and provided her with medical insurance through an employe benefit
plan that qualified as such under the Employee Retirement Income Security Act
of 1974, 29 U.S.C. § 1001 (ERISA).
The plan provided that "[i]f payment is made for services ... the
Company will be subrogated to all rights of recovery which the Covered Person
... may have against another party or liability insurer .... The Covered Person must do whatever is
reasonably necessary to secure the Company's rights and will do nothing to
damage the Company's rights." The
plan also required the insured to repay the company for benefits paid by the
plan as a result of medical malpractice.
Allegedly due to
malpractice, Gwendolyn incurred $234,000 in medical expenses that Venture I
paid under the plan. In March 1992, the
Lawvers retained Attorney William Sommerness to pursue their malpractice claim. For several months Sommerness communicated
with Venture I's agent about the case, including discussions whether Sommerness
would also represent Venture I if the Lawvers commenced suit.
Sommerness commenced the
Lawvers' suit in May 1993, naming Venture I and Certain Underwriters as
additional plaintiffs. In September
1993, he notified Venture I that he would not represent it, and recommended
that it obtain its own counsel. The
Lawvers then settled with the defendants for $160,000, and on October 11 moved
for an order determining the allocation of the settlement proceeds. Venture I asserts that it first learned of
the lawsuit on October 8. After the
hearing on the motion, held November 29, the court concluded, pursuant to Rimes
v. State Farm Mut. Auto. Ins. Co., 106 Wis.2d 263, 316 N.W.2d 348
(1982), that the Lawvers were entitled to the entire settlement amount because
they were not "made whole" by the settlement.
On appeal, Venture I
argues (1) that federal preemption bars the Rimes "made
whole" rule from applying to the subrogation rights of an ERISA benefit
plan, (2) that the trial court caused Gwendolyn to breach her insurance
contract with Venture I, (3) that a Rimes allocation was
improper because the defendants received a Pierringer release (see
Pierringer v. Hoger, 21 Wis.2d 182, 124 N.W.2d 106 (1963)),
(4) that circumstances deprived Venture I of a meaningful opportunity to
participate in the lawsuit or settlement, and (5) that the settlement was
unreasonably low and reached in bad faith.
Federal law does not bar
application of the Rimes "made whole" rule. Under Rimes, an insurer is not
entitled to subrogation out of settlement proceeds unless the insured has been
made whole for the loss. Rimes,
106 Wis.2d at 271-72, 316 N.W.2d at 353.
In Sanders v. Scheideler, 816 F. Supp. 1338, 1346-47 (W.D.
Wis. 1993), aff'd by unpublished order, 25 F.3d 1053 (7th Cir. 1994),
the court held that where an ERISA benefit plan fails to designate whether the
plan or the beneficiary has priority to settlement proceeds, and fails to
provide its directors the necessary discretion to construe the plan
accordingly, subrogation for medical payments will not be allowed until the
insured is made whole. In Schultz
v. NEPCO Employees Mut. Benefit Assoc., Inc., 190 Wis.2d 743, 752-53,
528 N.W.2d 441, 445 (Ct. App. 1994), we adopted the Sanders
rule. That resolves the matter because
Venture I's benefit plan failed to designate its priority to the settlement
proceeds as required by Sanders, nor does it give its directors
discretion to assign that priority.
Gwendolyn did not breach
her subrogation contract with Venture I because that contract was not
enforceable until she was made whole.
As Rimes points out, whether an insurer claims an
equitable or contractual subrogation right makes no difference because the same
"made whole" rule applies in either case. Rimes, 106 Wis.2d at 270-71, 316 N.W.2d at
353. As a result, the court's
determination that the Lawvers were not made whole effectively nullified
Venture I's subrogation contract with Gwendolyn.
The nature of the
defendants' release did not prejudice Venture I. It notes that the Pierringer release preserved the
Lawvers' right to sue other potential tortfeasors. However, Venture I fails to explain why that fact works to its
disadvantage. If other tortfeasors are
ultimately sued and found liable, Venture I can only benefit.
Venture I had sufficient
opportunity to protect its interests in the matter. The subrogation interest survives an adverse Rimes
determination only if the plaintiff and tortfeasor settle without involving the
subrogated insurer and without submitting the issue of the subrogated
insurer's rights to the court. Schulte
v. Frazin, 176 Wis.2d 622, 635, 500 N.W.2d 305, 310 (1993). Here, Attorney Sommerness advised Venture I
weeks before the settlement that it should obtain counsel and have counsel
contact him. Venture I can only blame
itself for the failure to promptly do so.
When Venture I finally learned of the settlement in October it retained
counsel, who obtained a six-week delay in the Rimes hearing. Venture I then sought no further delay and
participated in the hearing without objection.
Venture I has not shown
why the settlement was unreasonable or reached in bad faith. The trial court made findings of fact that
the Lawvers engaged in good faith settlement negotiations and that
"considering the cost of litigation, the risks of litigation, including
those peculiar to substantiating medical malpractice claims before a jury, and
in light of the injuries sustained, the Plaintiffs arrived at a reasonable
settlement." We affirm those
findings because Venture I does not refer us to any evidence that would prove
them clearly erroneous.
By the Court.—Judgment
affirmed.
This opinion will not be
published. See Rule 809.23(1)(b)5, Stats.